Eventide Asset Management, LLC Oric Pharmaceuticals, Inc. Transaction History
Eventide Asset Management, LLC
- $5.26 Billion
- Q2 2025
A detailed history of Eventide Asset Management, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 951,433 shares of ORIC stock, worth $12.7 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
951,433Holding current value
$12.7 Million% of portfolio
0.18%Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
147Shares Held
91.9MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$96 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$88.4 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$88.1 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$70.8 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$64.7 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $530M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...